The role of Myeloperoxidase, reproductive hormones and thyrodism in polycystic ovary syndrome patients

This study was conducted at the Infertility Center at Al-Batool Teaching Hospital for Women and Children in Dyala Governorate from 08/22/2020 to 12/1/2020. It was followed up of 100 cases of women suffering from polycystic ovaries, and it was compared to the control group, which included 50 standard points and then confirmed. They are free of chronic diseases such as thyroid disease and diabetes. The study aims to assess the clinical and hormonal status by measuring LH, FSH, melatonin, , and the aetiology and risk factors for infertile women with polycystic ovary syndrome. . The concentration of hormones was measured for both women with the syndrome and those without the syndrome, including LH, as it was observed that the level of LH concentration increased significantly in women with the syndrome, as it reached a concentration of (17.61 +_4.320) compared to the non-affected (4.53 +_1.86). The level of FSH hormone reached its concentration in women Female patients with the syndrome, as its attention reached (3.20 +_1.57) compared with the control group (7.53 +_1.68) and The concentration of the myeloperoxidase enzyme was measured. Its attention was (2.65 +_1.22) compared with the control group (1.12 +_0.53).